Abstract:Background: Both SOX2 and microRNA-30e (miR-30e) were reported to be involved in esophageal cancer (EC) progression. However, whether there is correlation between SOX2 and miR-30e in EC cells remains undiscovered. Herein, this study was intended to explore the correlation between SOX2 and miR-30e in EC and the effect of this correlation on EC cell invasion. Methods: Following collection of EC tissues and cells, miR-30e, SOX2, miR-30e, USP4, SMAD4, and CK2 expression was determined by RT-qPCR, western blot analysis and immunohistochemistry. Gain- and loss-of-function approaches were conducted in screened cell lines, followed by determination of cell proliferation, migration, invasion, and expression of epithelial-mesenchymal transition (EMT)-related genes. The relationship among miR-30e, USP4, SMAD4 and CK2 was assessed by dual-luciferase reporter assay, in vitro protein purification, immunoprecipitation, and ubiquitination experiments, and ChIP assay. The role of SOX2 and CK2 in EC in vivo was evaluated by tumor xenograft in nude mice. Results: EC tissues and cells contained high expression of SOX2, miR-30e, and CK2 as well as low expression of USP4 and SMAD4. miR-30e was upregulated by SOX2, and specifically targeted USP4. Additionally, USP4 induced the deubiquitination of SMAD4 to upregulate SMAD4. SMAD4 was enriched in CK2 promoter region and inhibited CK2 expression. Silencing of SMAD4 or USP4 or upregulation of SOX2, miR-30e or CK2 triggered enhancement in EC cell proliferation, migration, invasion, and EMT in vitro, and promotion of tumor growth and lung metastasis in vivo. Conclusion: Taken together, our work reveals a novel SOX2-mediated regulatory axis that plays critical roles in the invasiveness of EC cells.Funding Statement: This work was supported by Youth Foundation of the National Natural Science Foundation of China (No. 81702971), Key Scientific Research Projects of Colleges and Universities of Henan Province (No. 18A320054), Science and Technology Research Projects of Henan Province (No. 182102310116) and Youth Talent Lifting Projects of Henan Province (No. 2020HYTP050)Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: The ethics committee of the First Affiliated Hospital of Zhengzhou University provided Ethical Approval for the experiments involved human beings in this study which were guided by the intentions of the Declaration of Helsinki. Ethical agreements were obtained from the donors or their relatives by written informed consent. The experiments involved animals were implemented in accordance with the principles embodied in the National Institutes of Health Guide for the Care and Use of Laboratory. Efforts were made to avoid all unnecessary distress to the animals.

Bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-3p targets SOCS1 to facilitate progression of esophageal cancer

Bone marrow mesenchymal stem cells-derived exosomal miR-145-5p reduced non-small cell lung cancer cell progression by targeting SOX9

Bone Marrow Mesenchymal Stem Cell (Bmsc) Exosomes Inhibit Angiogenesis And Enhance Autophagy Through Decreasing Mir-21 In Cervical Cancer

miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma

microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2.

SOX2-Upregulated microRNA-30e Promotes Cell Invasion in Esophageal Cancer via USP4/SMAD4/CK2 Axis

Inhibitory role of bone marrow mesenchymal stem cells-derived exosome in non-small-cell lung cancer: microRNA-30b-5p, EZH2 and PI3K/AKT pathway

Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer

Cutaneous squamous cell carcinoma-derived exosomal MicroRNA-31 acts as an oncogene by targeting the tumor suppressor RhoBTB1

MicroRNA‐196a‐5p facilitates the onset and progression via targeting ITM2B in esophageal squamous cell carcinoma

Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway

Bone marrow mesenchymal stem cells-derived exosomal microRNA-16-5p restrains epithelial-mesenchymal transition in breast cancer cells via EPHA1/NF-κB signaling axis

miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma

MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2/phosphatidylinositol 3‐kinase/Akt signaling pathway

MicroRNA‑181a promotes epithelial‑mesenchymal transition in esophageal squamous cell carcinoma via the TGF‑β/Smad pathway

Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)

CAFs-derived Exosomal miR-889-3p Might Repress M1 Macrophage Polarization to Boost ESCC Development by Regulating STAT1

MicroRNA-30b targets CBX3 and regulates cell proliferation, apoptosis, and migration in esophageal squamous cell carcinoma via the JAK2/STAT3 signaling pathway

miR-203a-3p regulates the cellular processes of esophageal cancer cells via targeting CtBP2

Effects of Mir‑106b‑3p on Cell Proliferation and Epithelial‑mesenchymal Transition, and Targeting of ZNRF3 in Esophageal Squamous Cell Carcinoma.

Cancer-associated fibroblast-derived exosome miR-181b-3p promotes the occurrence and development of colorectal cancer by regulating SNX2 expression